{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:15:20Z","timestamp":1780596920097,"version":"3.54.1"},"reference-count":179,"publisher":"Begell House","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Oncog"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>The oral microbiota plays a pivotal role in maintaining oral health, but its dysbiosis has been increasingly implicated in the development of systemic diseases, including cancer. Emerging evidence highlights the potential contribution of oral microorganisms to carcinogenesis in the oral cavity and distant organs, such as the lungs, pancreas, and genitourinary tract. This review explores the mechanisms through which the oral microbiota influences cancer development and treatment response, mainly driven by microbial translocation, systemic inflammation, immune modulation, and the release of carcinogenic metabolites. Additionally, the review discusses how oral microbiota perturbations interact with host factors, such as diet, systemic diseases, genetics, and cancer therapies, to influence tumor initiation, progression, and response to treatment. A critical analysis of past and emerging literature shows that specific microbial taxa potentially influence tumor progression and immune responses, including &lt;i&gt;Fusobacterium, Porphyromonas, Aggregatibacter&lt;\/i&gt; and &lt;i&gt;Treponema&lt;\/i&gt;. The detection of these microorganisms and the study of oral microbiome profiling in cancer care may offer new diagnostic and therapeutic strategies; however, further studies with homogeneous patient populations are needed to fully understand the contributions of oral dysbiosis in cancer development and treatment responses.\n<\/p>","DOI":"10.1615\/critrevoncog.2025059551","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T18:14:44Z","timestamp":1746555284000},"page":"83-106","source":"Crossref","is-referenced-by-count":3,"title":["Review Article: Disrupted Oral Microbiota and Its Implications in Cancer Onset and Progression: A Narrative Review"],"prefix":"10.1615","volume":"30","author":[{"given":"Giovanni","family":"Cultrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziana","family":"Spoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Libra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Falzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Santacroce L, Passarelli PC, Azzolino D, Bottalico L, Charitos IA, Cazzolla AP, Colella M, Topi S, Godoy FG, D'Addona A. Oral microbiota in human health and disease: A perspective. Exp Biol Med. 2023;248(15):1288-301.","DOI":"10.1177\/15353702231187645"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Chandra Nayak S, Latha PB, Kandanattu B, Pympallil U, Kumar A, Kumar Banga H. The oral microbiome and systemic health: Bridging the gap between dentistry and medicine. Cureus. 2025;17(2):e78918.","DOI":"10.7759\/cureus.78918"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Lavoro A, Cultrera G, Gattuso G, Lombardo C, Falzone L, Saverio C, Libra M, Salmeri M. Role of oral microbiota dysbiosis in the development and progression of oral lichen planus. J Pers Med. 2024;14(4):386.","DOI":"10.3390\/jpm14040386"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Li X, Liu Y, Yang X, Li C, Song Z. The oral microbiota: Community composition, influencing factors, pathogenesis, and interventions. Front Microbiol. 2022;13:895537.","DOI":"10.3389\/fmicb.2022.895537"},{"key":"6","doi-asserted-by":"crossref","unstructured":"La Rosa GRM, Gattuso G, Pedull\u00c3\u00a0 E, Rapisarda E, Nicolosi D, Salmeri M. Association of oral dysbiosis with oral cancer development. Oncol Lett. 2020;19(4):3045-58.","DOI":"10.3892\/ol.2020.11441"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Sudhakara P, Gupta A, Bhardwaj A, Wilson A. Oral dysbiotic communities and their implications in systemic diseases. Dent J. 2018;6(2):10.","DOI":"10.3390\/dj6020010"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Mascitti M, Togni L, Troiano G, Caponio VCA, Gissi DB, Montebugnoli L, Procaccini M, Lo Muzio L, Santarelli A. Beyond head and neck cancer: The relationship between oral microbiota and tumour development in distant organs. Front Cell Infect Microbiol. 2019;9:232.","DOI":"10.3389\/fcimb.2019.00232"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Sukmana BI, Saleh RO, Najim MA, Al-Ghamdi HS, Achmad H, Al-Hamdani MM, Taher AA, Alsalamy A, Khaledi M, Javadi K. Oral microbiota and oral squamous cell carcinoma: A review of their relation and carcinogenic mechanisms. Front Oncol. 2024;14:1319777.","DOI":"10.3389\/fonc.2024.1319777"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Sun J, Tang Q, Yu S, Xie M, Xie Y, Chen G, Chen L. Role of the oral microbiota in cancer evolution and progression. Cancer Med. 2020;9(17):6306-21.","DOI":"10.1002\/cam4.3206"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Wang B, Deng J, Donati V, Merali N, Frampton AE, Giovannetti E, Deng D. The roles and interactions of porphyromonas gingivalis and fusobacterium nucleatum in oral and gastrointestinal carcinogenesis: A narrative review. Pathogens. 2024;13(1):93.","DOI":"10.3390\/pathogens13010093"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Qin Y, Li Z, Liu T, Ma J, Liu H, Zhou Y, Wang S, Zhang L, Peng Q, Ye P, Duan N, Wang W, Wang X. Prevotella intermedia boosts OSCC progression through ISG15 upregulation: A new target for intervention. J Cancer Res Clin Oncol. 2024;150(4):206.","DOI":"10.1007\/s00432-024-05730-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Peng RT, Sun Y, Zhou XD, Liu SY, Han Q, Cheng L, Peng X. Treponema denticola Promotes OSCC development via the TGF-B signaling pathway. J Dent Res. 2022;101(6):704-13.","DOI":"10.1177\/00220345211067401"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Chiscuzzu F, Crescio C, Varrucciu S, Rizzo D, Sali M, Delogu G, Bussu F. Current evidence on the relation between microbiota and oral cancer: The role of fusobacterium nucleatum-a narrative review. Cancers. 2025;17(2):171.","DOI":"10.3390\/cancers17020171"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Guo X, Shao Y. Role of the oral-gut microbiota axis in pancreatic cancer: A new perspective on tumor pathophysiology, diagnosis, and treatment. Mol Med. 2025;31(1):103.","DOI":"10.1186\/s10020-025-01166-w"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Olsen I, Yilmaz \u00d6. Possible role of Porphyromonas gingivalis in orodigestive cancers. J Oral Microbiol. 2019;11(1):1563410.","DOI":"10.1080\/20002297.2018.1563410"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Rahman R, Shaikh MH, Gopinath D, Idris A, Johnson NW. Human papillomavirus and Epstein-Barr virus co-infection in oral and oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis. Mol Oral Microbiol. 2023;38(4):259-74.","DOI":"10.1111\/omi.12412"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Heng W, Wang W, Dai T, Jiang P, Lu Y, Li R, Zhang M, Xie R, Zhou Y, Zhao M, Duan N, Ye Z, Yan F, Wang X. Oral bacteriome and mycobiome across stages of oral carcinogenesis. Microbiol Spectr. 2022;10(6):e0273722.","DOI":"10.1128\/spectrum.02737-22"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Lin Y, Liang X, Li Z, Gong T, Ren B, Li Y, Peng X. Omics for deciphering oral microecology. Int J Oral Sci. 2024;16(1):2.","DOI":"10.1038\/s41368-023-00264-x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Long H, Yan L, Pu J, Liu Y, Zhong X, Wang H, Yang L, Lou F, Luo S, Zhang Y, Liu Y, Xie P, Ji P, Jin X. Multi-omics analysis reveals the effects of microbiota on oral homeostasis. Front Immunol. 2022;13:1005992.","DOI":"10.3389\/fimmu.2022.1005992"},{"key":"21","doi-asserted-by":"crossref","unstructured":"He B, Cao Y, Zhuang Z, Deng Q, Qiu Y, Pan L, Zheng X, Shi B, Lin L, Chen F. The potential value of oral microbial signatures for prediction of oral squamous cell carcinoma based on machine learning algorithms. Head Neck. 2024;46(7):1660-70.","DOI":"10.1002\/hed.27795"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Chattopadhyay I, Verma M, Panda M. Role of oral microbiome signatures in diagnosis and prognosis of oral cancer. Technol Cancer Res Treat. 2019;18:1533033819867354.","DOI":"10.1177\/1533033819867354"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Zhou X, Hao Y, Peng X, Li B, Han Q, Ren B, Li M, Li L, Li Y, Cheng G, Li J, Ma Y, Zhou X, Cheng L. The clinical potential of oral microbiota as a screening tool for oral squamous cell carcinomas. Front Cell Infect Microbiol. 2021;11:728933.","DOI":"10.3389\/fcimb.2021.728933"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Rezasoltani S, Aghdaei HA, Jasemi S, Gazouli M, Dovrolis N, Sadeghi A, Schl\u00c3\u00bcter H, Zali MR, Sechi LA, Feizabadi MM. Oral microbiota as novel biomarkers for colorectal cancer screening. Cancers. 2022;15(1):192.","DOI":"10.3390\/cancers15010192"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med. 2005;3:27.","DOI":"10.1186\/1479-5876-3-27"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Devaraja K, Aggarwal S. Dysbiosis of oral microbiome: A key player in oral carcinogenesis? A critical review. Biomedicines. 2025;13(2):448.","DOI":"10.3390\/biomedicines13020448"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Talapko J, Eri\u0107 S, Me\u0161trovi\u0107 T, Stipeti\u0107 MM, Juzba\u0161i\u0107 M, Katalini\u0107 D, Beki\u0107 S, Mur\u0161i\u0107 D, Flam J, Beli\u0107 D, Le\u0161i\u0107 D, Fure\u0161 R, Markanovi\u00c4\u0087 M, \u0160krlec I. The impact of oral microbiome dysbiosis on the aetiology, pathogenesis, and development of oral cancer. Cancers. 2024;16(17):2997.","DOI":"10.3390\/cancers16172997"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Acharya S, Hegde U, Acharya AB, Nitin P. Dysbiosis linking periodontal disease and oral squamous cell carcinoma: A brief narrative review. Heliyon. 2024;10(11):e32259.","DOI":"10.1016\/j.heliyon.2024.e32259"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Deo PN, Deshmukh RS, Gaike AH, Christopher A, Gujare M, Inamdar M. Oral microbiome profiles in oral potentially malignant disorders and oral cancer: A diagnostic perspective. J Oral Maxillofac Pathol. 2025;29(1):87-97.","DOI":"10.4103\/jomfp.jomfp_140_24"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Zhou J, Wang L, Yuan R, Yu X, Chen Z, Yang F, Sun G, Dong Q. Signatures of mucosal microbiome in oral squamous cell carcinoma identified using a random forest model. Cancer Manag Res. 2020;12:5353-63.","DOI":"10.2147\/CMAR.S251021"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Yan K, Auger S, Diaz A, Naman J, Vemulapalli R, Hasina R, Izumchenko E, Shogan B, Agrawal N. Microbial changes associated with oral cavity cancer progression. Otolaryngol Head Neck Surg. 2023;168(6):1443-52.","DOI":"10.1002\/ohn.211"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Akbari E, Epstein JB, Samim F. Unveiling the hidden links: Periodontal disease, fusobacterium nucleatum, and cancers. Curr Oncol Rep. 2024;26(11):1388-97.","DOI":"10.1007\/s11912-024-01591-w"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Chen Y, Huang Z, Tang Z, Huang Y, Huang M, Liu H, Ziebolz D, Schmalz G, Jia B, Zhao J. More than just a periodontal pathogen: The research progress on Fusobacterium nucleatum. Front Cell Infect Microbiol. 2022;12:815318.","DOI":"10.3389\/fcimb.2022.815318"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Groeger S, Zhou Y, Ruf S, Meyle J. Pathogenic mechanisms of fusobacterium nucleatum on oral epithelial cells. Front Oral Health. 2022;3:831607.","DOI":"10.3389\/froh.2022.831607"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Sun J, Feng S, Ding T, Wang T, Du L, Kang W, Ge S. Fusobacterium nucleatum dysregulates inflammatory cytokines and NLRP3 inflammasomes in oral cells. Oral Dis. 2024;30(7):4767-81.","DOI":"10.1111\/odi.14899"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Mikli\u00c4\u0087 K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42(2):344-55.","DOI":"10.1016\/j.immuni.2015.01.010"},{"key":"37","unstructured":"Gasmi Benahmed A, Kumar Mujawdiya P, Noor S, Gasmi A. Porphyromonas Gingivalis in the development of periodontitis: Impact on dysbiosis and inflammation. Arch Razi Inst. 2022;77(5):1539-51."},{"key":"38","doi-asserted-by":"crossref","unstructured":"Xu W, Zhou W, Wang H, Liang S. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis. Adv Protein Chem Struct Biol. 2020;120:45-84.","DOI":"10.1016\/bs.apcsb.2019.12.001"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Guo ZC, Jing SL, Jumatai S, Gong ZC. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment. Cancer Immunol Immunother. 2023;72(6):1523-39.","DOI":"10.1007\/s00262-022-03348-5"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Nakayama M, Inoue T, Naito M, Nakayama K, Ohara N. Attenuation of the phosphatidylinositol 3-kinase\/Akt signaling pathway by Porphyromonas gingivalis gingipains RgpA, RgpB, and Kgp. J Biol Chem. 2015;290(8):5190-202.","DOI":"10.1074\/jbc.M114.591610"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Saliem SS, Bede SY, Cooper PR, Abdulkareem AA, Milward MR, Abdullah BH. Pathogenesis of periodontitis: A potential role for epithelial-mesenchymal transition. Jpn Dent Sci Rev. 2022;58:268-78.","DOI":"10.1016\/j.jdsr.2022.09.001"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Hoare A, Soto C, Rojas-Celis V, Bravo D. Chronic inflammation as a link between periodontitis and carcinogenesis. Mediators Inflamm. 2019;2019:1029857.","DOI":"10.1155\/2019\/1029857"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Nwizu N, Wactawski-Wende J, Genco RJ. Periodontal disease and cancer: Epidemiologic studies and possible mechanisms. Periodontol 2000. 2020;83(1):213-33.","DOI":"10.1111\/prd.12329"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Mivehchi H, Eskandari-Yaghbastlo A, Pour Bahrami P, Elhami A, Faghihinia F, Nejati ST, Kazemi KS, Nabi Afjadi M. Exploring the role of oral bacteria in oral cancer: A narrative review. Discov Oncol. 2025;16(1):242.","DOI":"10.1007\/s12672-025-01998-2"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Di Cosola M, Cazzolla AP, Charitos IA, Ballini A, Inchingolo F, Santacroce L. Candida albicans and oral carcinogenesis. A brief review. J Fungi. 2021;7(6):476.","DOI":"10.3390\/jof7060476"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Stornetta A, Guidolin V, Balbo S. Alcohol-derived acetaldehyde exposure in the oral cavity. Cancers. 2018;10(1):20.","DOI":"10.3390\/cancers10010020"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Gao S, Sun R, Singh R, Yu So S, Chan CTY, Savidge T, Hu M. The role of gut microbial B-glucuronidase in drug disposition and development. Drug Discov Today. 2022;27(10):103316.","DOI":"10.1016\/j.drudis.2022.07.001"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Badawi AF, Hosny G, el-Hadary M, Mostafa MH. Salivary nitrate, nitrite and nitrate reductase activity in relation to risk of oral cancer in Egypt. Dis Markers. 1998;14(2):91-7.","DOI":"10.1155\/1998\/507653"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Ito N, Itoh N, Kameshima S. Volatile sulfur compounds produced by the anaerobic bacteria porphyromonas spp. isolated from the oral cavities of dogs. Vet Sci. 2023;10(8):503.","DOI":"10.3390\/vetsci10080503"},{"key":"50","unstructured":"Park JA, Lee GR, Lee JY, Jin BH. Oral probiotics, streptococcus salivarius K12 and M18, suppress the release of volatile sulfur compounds and a virulent protease from oral bacteria: An in-vitro study. Oral Health Prev Dent. 2023;21:259-70."},{"key":"51","doi-asserted-by":"crossref","unstructured":"Wu DD, Ngowi EE, Zhai YK, Wang YZ, Khan NH, Kombo AF, Khattak S, Li T, Ji XY. Role of hydrogen sulfide in oral disease. Oxid Med Cell Longev. 2022;2022:1886277.","DOI":"10.1155\/2022\/1886277"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Cai L, Zhu H, Mou Q, Wong PY, Lan L, Ng CWK, Lei P, Cheung MK, Wang D, Wong EWY, Lau EHL, Yeung ZWC, Lai R, Meehan K, Fung S, Chan KCA, Lui VWY, Cheng ASL, Yu J, Chan PKS, Chan JYK, Chen Z. Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma. NPJ Biofilms Microbiomes. 2024;10(1):39.","DOI":"10.1038\/s41522-024-00511-x"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Groeger SE, Meyle J. Epithelial barrier and oral bacterial infection. Periodontol 2000. 2015;69(1):46-67.","DOI":"10.1111\/prd.12094"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Bugueno IM, Batool F, Keller L, Kuchler-Bopp S, Benkirane-Jessel N, Huck O. Porphyromonas gingivalis bypasses epithelial barrier and modulates fibroblastic inflammatory response in an in vitro 3D spheroid model. Sci Rep. 2018;8(1):14914.","DOI":"10.1038\/s41598-018-33267-4"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Abe-Yutori M, Chikazawa T, Shibasaki K, Murakami S. Decreased expression of E-cadherin by Porphyromonas gingivalis-lipopolysaccharide attenuates epithelial barrier function. J Periodontal Res. 2017;52(1):42-50.","DOI":"10.1111\/jre.12367"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Suzuki R, Kamio N, Sugimoto K, Maruoka S, Gon Y, Kaneko T, Yonehara Y, Imai K. Periodontopathic bacterium Fusobacterium nucleatum affects matrix metalloproteinase-9 expression in human alveolar epithelial cells and mouse lung. In Vivo. 2022;36(2):649-56.","DOI":"10.21873\/invivo.12749"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Fardini Y, Wang X, T\u00e9moin S, Nithianantham S, Lee D, Shoham M, Han YW. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol. 2011;82(6):1468-80.","DOI":"10.1111\/j.1365-2958.2011.07905.x"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Goetting-Minesky MP, Godovikova V, Fenno JC. Approaches to understanding mechanisms of dentilisin protease complex expression in treponema denticola. Front Cell Infect Microbiol. 2021;11:668287.","DOI":"10.3389\/fcimb.2021.668287"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Miao D, Fenno JC, Timm JC, Joo NE, Kapila YL. The Treponema denticola chymotrypsin-like protease dentilisin induces matrix metalloproteinase-2-dependent fibronectin fragmentation in periodontal ligament cells. Infect Immun. 2011;79(2):806-11.","DOI":"10.1128\/IAI.01001-10"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Malinowski B, W\u00c4\u0099sierska A, Zalewska K, Soko\u00c5\u0082owska MM, Bursiewicz W, Socha M, Ozorowski M, Pawlak-Osi\u00c5\u0084ska K, Wici\u00c5\u0084ski M. The role of Tannerella forsythia and Porphyromonas gingivalis in pathogenesis of esophageal cancer. Infect Agent Cancer. 2019;14:3.","DOI":"10.1186\/s13027-019-0220-2"},{"key":"61","doi-asserted-by":"crossref","unstructured":"Johansson A. Aggregatibacter actinomycetemcomitans leukotoxin: A powerful tool with capacity to cause imbalance in the host inflammatory response. Toxins. 2011;3(3):242-59.","DOI":"10.3390\/toxins3030242"},{"key":"62","doi-asserted-by":"crossref","unstructured":"Patel M. Oral cavity and candida albicans: Colonisation to the development of infection. Pathogens. 2022;11(3):335.","DOI":"10.3390\/pathogens11030335"},{"key":"63","doi-asserted-by":"crossref","unstructured":"Naglik JR, K\u00f6nig A, Hube B, Gaffen SL. Candida albicans-epithelial interactions and induction of mucosal innate immunity. Curr Opin Microbiol. 2017;40:104-12.","DOI":"10.1016\/j.mib.2017.10.030"},{"key":"64","doi-asserted-by":"crossref","unstructured":"Basukala O, Banks L. The not-so-good, the bad and the ugly: HPV E5, E6 and E7 oncoproteins in the orchestration of carcinogenesis. Viruses. 2021;13(10):1892.","DOI":"10.3390\/v13101892"},{"key":"65","doi-asserted-by":"crossref","unstructured":"D'Costa ZJ, Jolly C, Androphy EJ, Mercer A, Matthews CM, Hibma MH. Transcriptional repression of E-cadherin by human papillomavirus type 16 E6. PLoS One. 2012;7(11):e48954.","DOI":"10.1371\/journal.pone.0048954"},{"key":"66","doi-asserted-by":"crossref","unstructured":"Ballini A, Dipalma G, Isacco CG, Boccellino M, Di Domenico M, Santacroce L, Nguy\u00e1\u00bb\u0085n KCD, Scacco S, Calvani M, Boddi A, Corcioli F, Quagliuolo L, Cantore S, Martelli FS, Inchingolo F. Oral microbiota and immune system crosstalk: A translational research. Biology. 2020;9(6):131.","DOI":"10.3390\/biology9060131"},{"key":"67","doi-asserted-by":"crossref","unstructured":"Jauregui CE, Wang Q, Wright CJ, Takeuchi H, Uriarte SM, Lamont RJ. Suppression of T-cell chemokines by porphyromonas gingivalis. Infect Immun. 2013;81(7):2288-95.","DOI":"10.1128\/IAI.00264-13"},{"key":"68","doi-asserted-by":"crossref","unstructured":"Ren J, Han X, Lohner H, Hoyle RG, Li J, Liang S, Wang HP. G infection upregulates PD-L1 expression on dendritic cells, suppresses CD8+ T-cell responses, and aggravates oral cancer. Cancer Immunol Res. 2023;11(3):290-305.","DOI":"10.1158\/2326-6066.CIR-22-0541"},{"key":"69","doi-asserted-by":"crossref","unstructured":"Glowczyk I, Wong A, Potempa B, Babyak O, Lech M, Lamont RJ, Potempa J, Koziel J. Inactive gingipains from P. gingivalis selectively skews T Cells toward a Th17 phenotype in an IL-6 dependent manner. Front Cell Infect Microbiol. 2017;7:140.","DOI":"10.3389\/fcimb.2017.00140"},{"key":"70","doi-asserted-by":"crossref","unstructured":"Torrungruang K, Jitpakdeebordin S, Charatkulangkun O, Gleebbua Y. Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, and Treponema denticola\/Prevotella intermedia co-infection are associated with severe periodontitis in a Thai population. PLoS One. 2015;10(8):e0136646.","DOI":"10.1371\/journal.pone.0136646"},{"key":"71","doi-asserted-by":"crossref","unstructured":"Krutyho\u00c5\u0082owa A, Strzelec K, Dziedzic A, Bereta GP, \u00c5\u0081azarz-Bartyzel K, Potempa J, Gawron K. Host and bacterial factors linking periodontitis and rheumatoid arthritis. Front Immunol. 2022;13:980805.","DOI":"10.3389\/fimmu.2022.980805"},{"key":"72","doi-asserted-by":"crossref","unstructured":"Medeiros MC, The S, Bellile E, Russo N, Schmitd L, Danella E, Singh P, Banerjee R, Bassis C, Murphy GR 3rd, Sartor MA, Lombaert I, Schmidt TM, Eisbruch A, Murdoch-Kinch CA, Rozek L, Wolf GT, Li G, Chen GY, D\u00e2\u0080\u0099Silva NJ. Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer. Microbiome. 2023;11(1):268.","DOI":"10.1186\/s40168-023-01677-w"},{"key":"73","doi-asserted-by":"crossref","unstructured":"Pai SI, Matheus HR, Guastaldi FPS. Effects of periodontitis on cancer outcomes in the era of immunotherapy. Lancet Healthy Longev. 2023;4(4):e166-e175.","DOI":"10.1016\/S2666-7568(23)00021-1"},{"key":"74","doi-asserted-by":"crossref","unstructured":"Gao S, Liu Y, Duan X, Liu K, Mohammed M, Gu Z, Ren J, Yakoumatos L, Yuan X, Lu L, Liang S, Li J, Scott DA, Lamont RJ, Zhou F, Wang H. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy. Br J Cancer. 2021;125(3):433-44.","DOI":"10.1038\/s41416-021-01419-5"},{"key":"75","doi-asserted-by":"crossref","unstructured":"Jiang SS, Xie YL, Xiao XY, Kang ZR, Lin XL, Zhang L, Li CS, Qian Y, Xu PP, Leng XX, Wang LW, Tu SP, Zhong M, Zhao G, Chen JX, Wang Z, Liu Q, Hong J, Chen HY, Chen YX, Fang JY. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer. Cell Host Microbe. 2023;31(5):781-97.e9.","DOI":"10.1016\/j.chom.2023.04.010"},{"key":"76","doi-asserted-by":"crossref","unstructured":"Lee KA, Shaw H, Bataille V, Nathan P. Campylobacteriosis following immunosuppression for immune checkpoint inhibitor-related toxicity. J Immunother Cancer. 2020;8(2):e000577.","DOI":"10.1136\/jitc-2020-000577"},{"key":"77","doi-asserted-by":"crossref","unstructured":"Wang J, Yang L, Mao X, Li Z, Lin X, Jiang C. Streptococcus salivarius-mediated CD8+ T cell stimulation required antigen presentation by macrophages in oral squamous cell carcinoma. Exp Cell Res. 2018;366(2):121-6.","DOI":"10.1016\/j.yexcr.2018.03.007"},{"key":"78","doi-asserted-by":"crossref","unstructured":"Li S, He M, Lei Y, Liu Y, Li X, Xiang X, Wu Q, Wang Q. Oral microbiota and tumor: A new perspective of tumor pathogenesis. Microorganisms. 2022;10(11):2206.","DOI":"10.3390\/microorganisms10112206"},{"key":"79","unstructured":"Sadeghi F, Sohrabi A, Zagai U, Andreasson A, Vieth M, Talley NJ, Agr\u00e9us L, Ye W. Oral microbiome dysbiosis is associated with precancerous lesions and disorders of upper gastrointestinal tract: A population-based study. J Am College Gastroenterol. 2022:10-4309."},{"key":"80","doi-asserted-by":"crossref","unstructured":"Kunath BJ, De Rudder C, Laczny CC, Letellier E, Wilmes P. The oral-gut microbiome axis in health and disease. Nat Rev Microbiol. 2024;22(12):791-805.","DOI":"10.1038\/s41579-024-01075-5"},{"key":"81","doi-asserted-by":"crossref","unstructured":"Park SY, Hwang BO, Lim M, Ok SH, Lee SK, Chun KS, Park KK, Hu Y, Chung WY, Song NY. Oral-gut microbiome axis in gastrointestinal disease and cancer. Cancers. 2021;13(9):2124.","DOI":"10.3390\/cancers13092124"},{"key":"82","doi-asserted-by":"crossref","unstructured":"Kong J, Liu Y, Qian M, Xing L, Gao S. The relationship between Porphyromonas gingivalis and oesophageal squamous cell carcinoma: A literature review. Epidemiol Infect. 2023;151:e69.","DOI":"10.1017\/S0950268823000298"},{"key":"83","doi-asserted-by":"crossref","unstructured":"Chiang HC, Hughes M, Chang WL. The role of microbiota in esophageal squamous cell carcinoma: A review of the literature. Thorac Cancer. 2023;14(28):2821-9.","DOI":"10.1111\/1759-7714.15096"},{"key":"84","doi-asserted-by":"crossref","unstructured":"Zeng R, Gou H, Lau HCH, Yu J. Stomach microbiota in gastric cancer development and clinical implications. Gut. 2024;73(12):2062-73.","DOI":"10.1136\/gutjnl-2024-332815"},{"key":"85","doi-asserted-by":"crossref","unstructured":"Xia R, Jiang Z, Zhou Y, Pan L, Wang Y, Ma Y, Fan L, Yuan L, Cheng X. Oral microbiota and gastric cancer: Recent highlights and knowledge gaps. J Oral Microbiol. 2024;16(1):2391640.","DOI":"10.1080\/20002297.2024.2391640"},{"key":"86","doi-asserted-by":"crossref","unstructured":"Pignatelli P, Nuccio F, Piattelli A, Curia MC. The role of fusobacterium nucleatum in oral and colorectal carcinogenesis. Microorganisms. 2023;11(9):2358.","DOI":"10.3390\/microorganisms11092358"},{"key":"87","doi-asserted-by":"crossref","unstructured":"Negrut RL, Cote A, Maghiar AM. Exploring the potential of oral microbiome biomarkers for colorectal cancer diagnosis and prognosis: A systematic review. Microorganisms. 2023;11(6):1586.","DOI":"10.3390\/microorganisms11061586"},{"key":"88","doi-asserted-by":"crossref","unstructured":"Peters BA, Wu J, Pei Z, Yang L, Purdue MP, Freedman ND, Jacobs EJ, Gapstur SM, Hayes RB, Ahn J. Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res. 2017;77(23):6777-87.","DOI":"10.1158\/0008-5472.CAN-17-1296"},{"key":"89","doi-asserted-by":"crossref","unstructured":"Jiang Z, Wang J, Qian X, Zhang Z, Wang S. Oral microbiota may predict the presence of esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2023;149(8): 4731-9.","DOI":"10.1007\/s00432-022-04393-4"},{"key":"90","doi-asserted-by":"crossref","unstructured":"Yano Y, Etemadi A, Abnet CC. Microbiome and cancers of the esophagus: A review. Microorganisms. 2021;9(8):1764.","DOI":"10.3390\/microorganisms9081764"},{"key":"91","doi-asserted-by":"crossref","unstructured":"Iljazovic A, Amend L, Galvez EJC, de Oliveira R, Strowig T. Modulation of inflammatory responses by gastrointestinal Prevotella spp.: From associations to functional studies. Int J Med Microbiol. 2021;311(2):151472.","DOI":"10.1016\/j.ijmm.2021.151472"},{"key":"92","doi-asserted-by":"crossref","unstructured":"Trautmann A, Schleicher L, Deusch S, G\u00c3\u00a4tgens J, Steuber J, Seifert J. Short-chain fatty acids modulate metabolic pathways and membrane lipids in Prevotella bryantii B14. Proteomes. 2020;8(4):28.","DOI":"10.3390\/proteomes8040028"},{"key":"93","doi-asserted-by":"crossref","unstructured":"Natarajan N, Pluznick JL. From microbe to man: The role of microbial short chain fatty acid metabolites in host cell biology. Am J Physiol Cell Physiol. 2014;307(11):C979-C985.","DOI":"10.1152\/ajpcell.00228.2014"},{"key":"94","doi-asserted-by":"crossref","unstructured":"Narikiyo M, Tanabe C, Yamada Y, Igaki H, Tachimori Y, Kato H, Muto M, Montesano R, Sakamoto H, Nakajima Y, Sasaki H. Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer Sci. 2004;95(7):569-74.","DOI":"10.1111\/j.1349-7006.2004.tb02488.x"},{"key":"95","doi-asserted-by":"crossref","unstructured":"Kelk P, Moghbel NS, Hirschfeld J, Johansson A. Aggregatibacter actinomycetemcomitans leukotoxin activates the NLRP3 inflammasome and cell-to-cell communication. Pathogens. 2022;11(2):159.","DOI":"10.3390\/pathogens11020159"},{"key":"96","doi-asserted-by":"crossref","unstructured":"Kawasaki M, Ikeda Y, Ikeda E, Takahashi M, Tanaka D, Nakajima Y, Arakawa S, Izumi Y, Miyake S. Oral infectious bacteria in dental plaque and saliva as risk factors in patients with esophageal cancer. Cancer. 2021;127(4):512-9.","DOI":"10.1002\/cncr.33316"},{"key":"97","doi-asserted-by":"crossref","unstructured":"Kato I, Minkevitch J, Sun J. Oncogenic potential of campylobacter infection in the gastrointestinal tract: Narrative review. Scand J Gastroenterol. 2023;58(12):1453-65.","DOI":"10.1080\/00365521.2023.2228954"},{"key":"98","doi-asserted-by":"crossref","unstructured":"Kaakoush NO, Deshpande NP, Man SM, Burgos-Portugal JA, Khattak FA, Raftery MJ, Wilkins MR, Mitchell HM. Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus. Infect Immun. 2015;83(2):832-45.","DOI":"10.1128\/IAI.03012-14"},{"key":"99","doi-asserted-by":"crossref","unstructured":"Wicaksono DP, Washio J, Abiko Y, Domon H, Takahashi N. Nitrite production from nitrate and its link with lactate metabolism in oral Veillonella spp. Appl Environ Microbiol. 2020;86(20):e01255-20.","DOI":"10.1128\/AEM.01255-20"},{"key":"100","doi-asserted-by":"crossref","unstructured":"Seyyedsalehi MS, Mohebbi E, Tourang F, Sasanfar B, Boffetta P, Zendehdel K. Association of dietary nitrate, nitrite, and n-nitroso compounds intake and gastrointestinal cancers: A systematic review and meta-analysis. Toxics. 2023;11(2):190.","DOI":"10.3390\/toxics11020190"},{"key":"101","unstructured":"Sasaki H, Ishizuka T, Muto M, Nezu M, Nakanishi Y, Inagaki Y, Watanabe H, Watanabe H, Terada M. Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer. Cancer Res. 1998;58(14):2991-5. PMID: 9679961."},{"key":"102","doi-asserted-by":"crossref","unstructured":"Xia K, Zhou Y, Wang W, Cai Y. Streptococcus anginosus: The potential role in the progression of gastric cancer. J Cancer Res Clin Oncol. 2025;151(4):143.","DOI":"10.1007\/s00432-025-06201-1"},{"key":"103","doi-asserted-by":"crossref","unstructured":"Delsing CE, Bleeker-Rovers CP, van de Veerdonk FL, Tol J, van der Meer JW, Kullberg BJ, Netea MG. Association of esophageal candidiasis and squamous cell carcinoma. Med Mycol Case Rep. 2012;1(1):5-8.","DOI":"10.1016\/j.mmcr.2012.02.003"},{"key":"104","doi-asserted-by":"crossref","unstructured":"Dan W, Peng L, Yan B, Li Z, Pan F. human microbiota in esophageal adenocarcinoma: Pathogenesis, diagnosis, prognosis and therapeutic implications. Front Microbiol. 2022;12:791274.","DOI":"10.3389\/fmicb.2021.791274"},{"key":"105","doi-asserted-by":"crossref","unstructured":"Chen Y, Lei L, Xia M, Cheng R, Cai H, Hu T. The association between oral microbiome and gastric precancerous lesions. mSystems. 2025;10(1):e0132224.","DOI":"10.1128\/msystems.01322-24"},{"key":"106","doi-asserted-by":"crossref","unstructured":"Bakhti SZ, Latifi-Navid S. Oral microbiota and Helicobacter pylori in gastric carcinogenesis: What do we know and where next? BMC Microbiol. 2021;21(1):71.","DOI":"10.1186\/s12866-021-02130-4"},{"key":"107","doi-asserted-by":"crossref","unstructured":"Filardo S, Scalese G, Virili C, Pontone S, Di Pietro M, Covelli A, Bedetti G, Marinelli P, Bruno G, Stramazzo I, Centanni M, Sessa R, Severi C. The Potential role of hypochlorhydria in the development of duodenal dysbiosis: A preliminary report. Front Cell Infect Microbiol. 2022;12:854904.","DOI":"10.3389\/fcimb.2022.854904"},{"key":"108","doi-asserted-by":"crossref","unstructured":"Petkevicius V, Lehr K, Kupcinskas J, Link A. Fusobacterium nucleatum: Unraveling its potential role in gastric carcinogenesis. World J Gastroenterol. 2024;30(35): 3972-84.","DOI":"10.3748\/wjg.v30.i35.3972"},{"key":"109","doi-asserted-by":"crossref","unstructured":"Hsieh YY, Tung SY, Pan HY, Chang TS, Wei KL, Chen WM, Deng YF, Lu CK, Lai YH, Wu CS, Li C. Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients. World J Gastroenterol. 2021;27(42):7311-23.","DOI":"10.3748\/wjg.v27.i42.7311"},{"key":"110","doi-asserted-by":"crossref","unstructured":"Liu D, Zhang R, Chen S, Sun B, Zhang K. Analysis of gastric microbiome reveals three distinctive microbial communities associated with the occurrence of gastric cancer. BMC Microbiol. 2022;22(1):184.","DOI":"10.1186\/s12866-022-02594-y"},{"key":"111","doi-asserted-by":"crossref","unstructured":"Nguyen DK, Kang MJ, Oh SJ, Park HJ, Kim SH, Yu JH, Lee Y, Lee HS, Yang JW, Seo Y, Ahn JS, Kim HS. Parvimonas micra-polarized M2-like tumor-associated macrophages accelerate colorectal cancer development via IL-8 secretion. Anim Cells Syst. 2024;29(1):24-34.","DOI":"10.1080\/19768354.2024.2442401"},{"key":"112","doi-asserted-by":"crossref","unstructured":"Liang W, Zhou Z, Gao Q, Zhu Z, Zhu J, Lin J, Wen Y, Qian F, Wang L, Zhai Y, Lv J, Zhang H, Zhong F, Du H. Tumor-derived prevotella intermedia aggravates gastric cancer by enhancing Perilipin 3 expression. Cancer Sci. 2024;115(4):1141-53.","DOI":"10.1111\/cas.16080"},{"key":"113","doi-asserted-by":"crossref","unstructured":"Khosravi Y, Dieye Y, Loke MF, Goh KL, Vadivelu J. Streptococcus mitis induces conversion of Helicobacter pylori to coccoid cells during co-culture in vitro. PLoS One. 2014;9(11):e112214.","DOI":"10.1371\/journal.pone.0112214"},{"key":"114","doi-asserted-by":"crossref","unstructured":"Lei L, Zhao L-Y, Cheng R, Zhang H, Xia M, Chen X-L, Kudriashov V, Liu K, Zhang W-H, Jiang H, Chen Y, Zhu L, Zhou H, Yang K, Hu T, Hu J-K. Distinct oral-associated gastric microbiota and Helicobacter pylori communities for spatial microbial heterogeneity in gastric cancer. mSystems. 2024;9(7):e0008924.","DOI":"10.1128\/msystems.00089-24"},{"key":"115","doi-asserted-by":"crossref","unstructured":"Zhong M, Xiong Y, Zhao J, Gao Z, Ma J, Wu Z, Song Y, Hong X. Candida albicans disorder is associated with gastric carcinogenesis. Theranostics. 2021;11(10):4945\u00e2\u0080\u009356.","DOI":"10.7150\/thno.55209"},{"key":"116","doi-asserted-by":"crossref","unstructured":"Wei AL, Li M, Li GQ, Wang X, Hu WM, Li ZL, Yuan J, Liu HY, Zhou LL, Li K, Li A, Fu MR. Oral microbiome and pancreatic cancer. World J Gastroenterol. 2020;26(48):7679-92.","DOI":"10.3748\/wjg.v26.i48.7679"},{"key":"117","doi-asserted-by":"crossref","unstructured":"Saba E, Farhat M, Daoud A, Khashan A, Forkush E, Menahem NH, Makkawi H, Pandi K, Angabo S, Kawasaki H, Plaschkes I, Parnas O, Zamir G, Atlan K, Elkin M, Katz L, Nussbaum G. Oral bacteria accelerate pancreatic cancer development in mice. Gut. 2024;73(5):770-86.","DOI":"10.1136\/gutjnl-2023-330941"},{"key":"118","doi-asserted-by":"crossref","unstructured":"Gnanasekaran J, Binder Gallimidi A, Saba E, Pandi K, Eli Berchoer L, Hermano E, Angabo S, Makkawi HA, Khashan A, Daoud A, Elkin M, Nussbaum G. Intracellular Porphyromonas gingivalis promotes the tumorigenic behavior of pancreatic carcinoma cells. Cancers. 2020;12(8):2331.","DOI":"10.3390\/cancers12082331"},{"key":"119","doi-asserted-by":"crossref","unstructured":"Hayashi M, Ikenaga N, Nakata K, Luo H, Zhong P, Date S, Oyama K, Higashijima N, Kubo A, Iwamoto C, Torata N, Abe T, Yamada Y, Ohuchida K, Oda Y, Nakamura M. Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis. Cancer Sci. 2023;114(9):3666-78.","DOI":"10.1111\/cas.15901"},{"key":"120","doi-asserted-by":"crossref","unstructured":"Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, Kanno S, Igarashi H, Naito T, Adachi Y, Tachibana M, Tanuma T, Maguchi H, Shinohara T, Hasegawa T, Imamura M, Kimura Y, Hirata K, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget. 2015;6(9):7209-20.","DOI":"10.18632\/oncotarget.3109"},{"key":"121","doi-asserted-by":"crossref","unstructured":"Belibasakis GN, Maula T, Bao K, Lindholm M, Bostanci N, Oscarsson J, Ihalin R, Johansson A. Virulence and pathogenicity properties of aggregatibacter actinomycetemcomitans. Pathogens. 2019;8(4):222.","DOI":"10.3390\/pathogens8040222"},{"key":"122","doi-asserted-by":"crossref","unstructured":"Fan X, Alekseyenko AV, Wu J, Peters BA, Jacobs EJ, Gapstur SM, Purdue MP, Abnet CC, Stolzenberg-Solomon R, Miller G, Ravel J, Hayes RB, Ahn J. Human oral microbiome and prospective risk for pancreatic cancer: A population-based nested case-control study. Gut. 2018;67(1):120-7.","DOI":"10.1136\/gutjnl-2016-312580"},{"key":"123","doi-asserted-by":"crossref","unstructured":"\u00d6\u011frendik M. Periodontal pathogens in the etiology of pancreatic cancer. Gastrointest Tumors. 2017;3(3-4):125-7.","DOI":"10.1159\/000452708"},{"key":"124","doi-asserted-by":"crossref","unstructured":"Brayer KJ, Hanson JA, Cingam S, Martinez C, Ness SA, Rabinowitz I. The immune response to a fungus in pancreatic cancer samples. bioRxiv [Preprint]. 2023:2023.03.28.534606.","DOI":"10.1101\/2023.03.28.534606"},{"key":"125","doi-asserted-by":"crossref","unstructured":"Wang H, Capula M, Krom BP, Yee D, Giovannetti E, Deng D. Of fungi and men: Role of fungi in pancreatic cancer carcinogenesis. Ann Transl Med. 2020;8(19):1257.","DOI":"10.21037\/atm-20-2723"},{"key":"126","doi-asserted-by":"crossref","unstructured":"Lombardo C, Fazio R, Sinagra M, Gattuso G, Longo F, Lombardo C, Salmeri M, Zangh\u00c3\u00ac GN, Loreto CAE. Intratumoral microbiota: Insights from anatomical, molecular, and clinical perspectives. J Pers Med. 2024;14(11):1083.","DOI":"10.3390\/jpm14111083"},{"key":"127","doi-asserted-by":"crossref","unstructured":"Herremans KM, Riner AN, Cameron ME, McKinley KL, Triplett EW, Hughes SJ, Trevino JG. The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine. Microbiome. 2022;10(1):93.","DOI":"10.1186\/s40168-022-01262-7"},{"key":"128","doi-asserted-by":"crossref","unstructured":"Uguz A, Muftuoglu C, Mert U, Gumus T, Ece D, Asadi M, Bagci OU, Caner A. Unveiling microbiota profiles in saliva and pancreatic tissues of patients with pancreatic cancer. Microorganisms. 2025;13(1):119.","DOI":"10.3390\/microorganisms13010119"},{"key":"129","doi-asserted-by":"crossref","unstructured":"Cama\u00f1es-Gonzalvo S, Montiel-Company JM, Lobo-de-Mena M, Safont-Aguilera MJ, Fern\u00e1ndez-Diaz A, L\u00f3pez-Rold\u00c3\u00a1n A, Paredes-Gallardo V, Bellot-Arc\u00eds C. Relationship between oral microbiota and colorectal cancer: A systematic review. J Periodontal Res. 2024;59(6):1071-82.","DOI":"10.1111\/jre.13289"},{"key":"130","doi-asserted-by":"crossref","unstructured":"Mo S, Ru H, Huang M, Cheng L, Mo X, Yan L. Oral-intestinal microbiota in colorectal cancer: Inflammation and immunosuppression. J Inflamm Res. 2022;15:747-59.","DOI":"10.2147\/JIR.S344321"},{"key":"131","doi-asserted-by":"crossref","unstructured":"Ou S, Wang H, Tao Y, Luo K, Ye J, Ran S, Guan Z, Wang Y, Hu H, Huang R. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism. Front Cell Infect Microbiol. 2022;12:1020583.","DOI":"10.3389\/fcimb.2022.1020583"},{"key":"132","doi-asserted-by":"crossref","unstructured":"Galasso L, Termite F, Mignini I, Esposto G, Borriello R, Vitale F, Nicoletti A, Paratore M, Ainora ME, Gasbarrini A, Zocco MA. Unraveling the role of Fusobacterium nucleatum in colorectal cancer: Molecular mechanisms and pathogenic insights. Cancers. 2025;17(3):368.","DOI":"10.3390\/cancers17030368"},{"key":"133","doi-asserted-by":"crossref","unstructured":"Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, Chen Y, Chen H, Hong J, Zou W, Fang JY. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170(3):548-563.e16.","DOI":"10.1016\/j.cell.2017.07.008"},{"key":"134","doi-asserted-by":"crossref","unstructured":"Kaliamoorthy S, Priya Sayeeram S, Gowdhaman N, Jayaraj M, Radhika B, Chellapandi S, Elumalai A, Archana SP, Raju K, Palla S. Association of periodontal red complex bacteria with the incidence of gastrointestinal cancers: A systematic review and meta-analysis. Cureus. 2024;16(4):e59251.","DOI":"10.7759\/cureus.59251"},{"key":"135","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Basabe A, Lattanzi G, Perillo F, Amoroso C, Baeri A, Farini A, Torrente Y, Penna G, Rescigno M, Ghidini M, Cassinotti E, Baldari L, Boni L, Vecchi M, Caprioli F, Facciotti F, Strati F. Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion. Gut Microbes. 2024;16(1):2388801.","DOI":"10.1080\/19490976.2024.2388801"},{"key":"136","doi-asserted-by":"crossref","unstructured":"Rezasoltani S, Azizmohammad Looha M, Asadzadeh Aghdaei H, Jasemi S, Sechi LA, Gazouli M, Sadeghi A, Torkashvand S, Baniali R, Schl\u00c3\u00bcter H, Zali MR, Feizabadi MM. 16S rRNA sequencing analysis of the oral and fecal microbiota in colorectal cancer positives versus colorectal cancer negatives in Iranian population. Gut Pathog. 2024;16(1):9.","DOI":"10.1186\/s13099-024-00604-0"},{"key":"137","doi-asserted-by":"crossref","unstructured":"Long X, Wong CC, Tong L, Chu ESH, Ho Szeto C, Go MYY, Coker OO, Chan AWH, Chan FKL, Sung JJY, Yu J. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity. Nat Microbiol. 2019;4(12):2319-30.","DOI":"10.1038\/s41564-019-0541-3"},{"key":"138","doi-asserted-by":"crossref","unstructured":"DeDecker L, Coppedge B, Avelar-Barragan J, Karnes W, Whiteson K. Microbiome distinctions between the CRC carcinogenic pathways. Gut Microbes. 2021;13(1):1854641.","DOI":"10.1080\/19490976.2020.1854641"},{"key":"139","doi-asserted-by":"crossref","unstructured":"Chang Y, Long M, Shan H, Liu L, Zhong S, Luo JL. Combining gut microbiota modulation and immunotherapy: A promising approach for treating microsatellite stable colorectal cancer. Crit Rev Oncol Hematol. 2025;208:104629.","DOI":"10.1016\/j.critrevonc.2025.104629"},{"key":"140","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhang Y, Gui X, Zhang Y, Zhang Z, Chen W, Zhang X, Wang Y, Zhang M, Shang Z, Xin Y, Zhang Y. Salivary Fusobacterium nucleatum serves as a potential biomarker for colorectal cancer. iScience. 2022;25(5):104203.","DOI":"10.1016\/j.isci.2022.104203"},{"key":"141","doi-asserted-by":"crossref","unstructured":"Huang K, Gao X, Wu L, Yan B, Wang Z, Zhang X, Peng L, Yu J, Sun G, Yang Y. Salivary microbiota for gastric cancer prediction: An exploratory study. Front Cell Infect Microbiol. 2021;11:640309.","DOI":"10.3389\/fcimb.2021.640309"},{"key":"142","doi-asserted-by":"crossref","unstructured":"Falzone L, Lavoro A, Candido S, Salmeri M, Zangh\u00c3\u00ac A, Libra M. Benefits and concerns of probiotics: An overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain. Gut Microbes. 2024;16(1):2397874.","DOI":"10.1080\/19490976.2024.2397874"},{"key":"143","doi-asserted-by":"crossref","unstructured":"Salemi R, Vivarelli S, Ricci D, Scillato M, Santagati M, Gattuso G, Falzone L, Libra M. Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant. J Transl Med. 2023;21(1):195.","DOI":"10.1186\/s12967-023-04036-3"},{"key":"144","doi-asserted-by":"crossref","unstructured":"Sun Y, Liu Y, Li J, Tan Y, An T, Zhuo M, Pan Z, Ma M, Jia B, Zhang H, Wang Z, Yang R, Bi Y. Characterization of lung and oral microbiomes in lung cancer patients using culturomics and 16S rRNA gene sequencing. Microbiol Spectr. 2023;11(3):e0031423.","DOI":"10.1128\/spectrum.00314-23"},{"key":"145","doi-asserted-by":"crossref","unstructured":"Chu S, Cheng Z, Yin Z, Xu J, Wu F, Jin Y, Yang G. Airway Fusobacterium is associated with poor response to immunotherapy in lung cancer. Onco Targets Ther. 2022;15:201-13.","DOI":"10.2147\/OTT.S348382"},{"key":"146","doi-asserted-by":"crossref","unstructured":"Huang D, Chen Y, Li C, Yang S, Lin L, Zhang X, Su X, Liu L, Zhao H, Luo T, Cai S, Ren Q, Dong H. Variations in salivary microbiome and metabolites are associated with immunotherapy efficacy in patients with advanced NSCLC. mSystems. 2025;10(3):e0111524.","DOI":"10.1128\/msystems.01115-24"},{"key":"147","doi-asserted-by":"crossref","unstructured":"Huang L, Jiang C, Yan M, Wan W, Li S, Xiang Z, Wu J. The oral-gut microbiome axis in breast cancer: From basic research to therapeutic applications. Front Cell Infect Microbiol. 2024;14:1413266.","DOI":"10.3389\/fcimb.2024.1413266"},{"key":"148","doi-asserted-by":"crossref","unstructured":"Wang H, Altemus J, Niazi F, Green H, Calhoun BC, Sturgis C, Grobmyer SR, Eng C. Breast tissue, oral and urinary microbiomes in breast cancer. Oncotarget. 2017;8(50):88122-38.","DOI":"10.18632\/oncotarget.21490"},{"key":"149","doi-asserted-by":"crossref","unstructured":"Terrisse S, Zitvogel L, Kroemer G. Impact of microbiota on breast cancer hormone therapy. Cell Stress. 2023;7(3):12-9.","DOI":"10.15698\/cst2023.03.277"},{"key":"150","doi-asserted-by":"crossref","unstructured":"Klymiuk I, Bilgilier C, Mahnert A, Prokesch A, Heininger C, Brandl I, Sahbegovic H, Singer C, Fuereder T, Steininger C. Chemotherapy-associated oral microbiome changes in breast cancer patients. Front Oncol. 2022;12:949071.","DOI":"10.3389\/fonc.2022.949071"},{"key":"151","doi-asserted-by":"crossref","unstructured":"Yuan S, Fang C, Leng WD, Wu L, Li BH, Wang XH, Hu H, Zeng XT. Oral microbiota in the oral-genitourinary axis: Identifying periodontitis as a potential risk of genitourinary cancers. Mil Med Res. 2021;8(1):54.","DOI":"10.1186\/s40779-021-00344-1"},{"key":"152","unstructured":"da Silva APB, Alluri LSC, Bissada NF, Gupta S. Association between oral pathogens and prostate cancer: Building the relationship. Am J Clin Exp Urol. 2019;7(1):1-10."},{"key":"153","doi-asserted-by":"crossref","unstructured":"Nearing JT, DeClercq V, Langille MGI. Investigating the oral microbiome in retrospective and prospective cases of prostate, colon, and breast cancer. NPJ Biofilms Microbiomes. 2023;9(1):23.","DOI":"10.1038\/s41522-023-00391-7"},{"key":"154","doi-asserted-by":"crossref","unstructured":"Zhang W, Yin Y, Jiang Y, Yang Y, Wang W, Wang X, Ge Y, Liu B, Yao L. Relationship between vaginal and oral microbiome in patients of human papillomavirus (HPV) infection and cervical cancer. J Transl Med. 2024;22(1): 396.","DOI":"10.1186\/s12967-024-05124-8"},{"key":"155","doi-asserted-by":"crossref","unstructured":"Javadi K, Ferdosi-Shahandashti E, Rajabnia M, Khaledi M. Vaginal microbiota and gynecological cancers: A complex and evolving relationship. Infect Agent Cancer. 2024;19(1):27.","DOI":"10.1186\/s13027-024-00590-7"},{"key":"156","doi-asserted-by":"crossref","unstructured":"Giordano-Kelhoffer B, Lorca C, March Llanes J, R\u00c3\u00a1bano A, Del Ser T, Serra A, Gallart-Palau X. Oral microbiota, its equilibrium and implications in the pathophysiology of human diseases: A systematic review. Biomedicines. 2022;10(8):1803.","DOI":"10.3390\/biomedicines10081803"},{"key":"157","doi-asserted-by":"crossref","unstructured":"Su Y, Chen C, Guo L, Du J, Li X, Liu Y. Ecological balance of oral microbiota is required to maintain oral mesenchymal stem cell homeostasis. Stem Cells. 2018;36(4):551-61.","DOI":"10.1002\/stem.2762"},{"key":"158","doi-asserted-by":"crossref","unstructured":"Maier T. Oral microbiome in health and disease: Maintaining a healthy, balanced ecosystem and reversing dysbiosis. Microorganisms. 2023;11(6):1453.","DOI":"10.3390\/microorganisms11061453"},{"key":"159","doi-asserted-by":"crossref","unstructured":"Angarita-D\u00ef\u00bf\u00bdaz MDP, Fong C, Bedoya-Correa CM, Cabrera-Arango CL. Does high sugar intake really alter the oral microbiota?: A systematic review. Clin Exp Dent Res. 2022;8(6):1376-90.","DOI":"10.1002\/cre2.640"},{"key":"160","doi-asserted-by":"crossref","unstructured":"Hansen TH, Kern T, Bak EG, Kashani A, Allin KH, Nielsen T, Hansen T, Pedersen O. Impact of a vegan diet on the human salivary microbiota. Sci Rep. 2018;8(1):5847.","DOI":"10.1038\/s41598-018-24207-3"},{"key":"161","doi-asserted-by":"crossref","unstructured":"Fiore M, Minni A, Cavalcanti L, Raponi G, Puggioni G, Mattia A, Gariglio S, Colizza A, Meliante PG, Zoccali F, Tarani L, Barbato C, Lucarelli M, Ceci FM, Francati S, Ferraguti G, Ceccanti M, Petrella C. The Impact of alcohol consumption and oral microbiota on upper aerodigestive tract carcinomas: A pilot study. Antioxidants. 2023;12(6):1233.","DOI":"10.3390\/antiox12061233"},{"key":"162","doi-asserted-by":"crossref","unstructured":"Hallang S, Esberg A, Haworth S, Johansson I. healthy oral lifestyle behaviours are associated with favourable composition and function of the oral microbiota. Microorganisms. 2021;9(8):1674.","DOI":"10.3390\/microorganisms9081674"},{"key":"163","doi-asserted-by":"crossref","unstructured":"Brookes Z, Teoh L, Cieplik F, Kumar P. Mouthwash effects on the oral microbiome: Are they good, bad, or balanced? Int Dent J. 2023;73 (Suppl 2):S74-S81.","DOI":"10.1016\/j.identj.2023.08.010"},{"key":"164","doi-asserted-by":"crossref","unstructured":"D'Ambrosio F, Santella B, Di Palo MP, Giordano F, Lo Giudice R. Characterization of the Oral microbiome in wearers of fixed and removable implant or non-implant-supported prostheses in healthy and pathological oral conditions: A narrative review. Microorganisms. 2023;11(4):1041.","DOI":"10.3390\/microorganisms11041041"},{"key":"165","doi-asserted-by":"crossref","unstructured":"Monteiro DR, de Souza Batista VE, Caldeir\u00c3\u00a3o ACM, Jacinto RC, Pessan JP. Oral prosthetic microbiology: Aspects related to the oral microbiome, surface properties, and strategies for controlling biofilms. Biofouling. 2021;37(4):353-71.","DOI":"10.1080\/08927014.2021.1912741"},{"key":"166","doi-asserted-by":"crossref","unstructured":"Lyons KM, Cannon RD, Beumer J 3rd, Bakr MM, Love RM. The role of biofilms and material surface characteristics in microbial adhesion to maxillary obturator materials: A literature review. Cleft Palate Craniofac J. 2020;57(4):487-98.","DOI":"10.1177\/1055665619882555"},{"key":"167","doi-asserted-by":"crossref","unstructured":"Huang X, Huang X, Huang Y, Zheng J, Lu Y, Mai Z, Zhao X, Cui L, Huang S. The oral microbiome in autoimmune diseases: Friend or foe? J Transl Med. 2023;21(1):211.","DOI":"10.1186\/s12967-023-03995-x"},{"key":"168","doi-asserted-by":"crossref","unstructured":"Bartnicka D, Gonzalez-Gonzalez M, Sykut J, Koziel J, Ciaston I, Adamowicz K, Bras G, Zawrotniak M, Karkowska-Kuleta J, Satala D, Kozik A, Zyla E, Gawron K, Lazarz-Bartyzel K, Chomyszyn-Gajewska M, Rapala-Kozik M. Candida albicans shields the periodontal killer Porphyromonas gingivalis from recognition by the host immune system and supports the bacterial infection of gingival tissue. Int J Mol Sci. 2020;21(6):1984.","DOI":"10.3390\/ijms21061984"},{"key":"169","doi-asserted-by":"crossref","unstructured":"Freire M, Moustafa A, Harkins DM, Torralba MG, Zhang Y, Leong P, Saffery R, Bockmann M, Kuelbs C, Hughes T, Craig JM, Nelson KE. Longitudinal study of oral microbiome variation in twins. Sci Rep. 2020;10(1):7954.","DOI":"10.1038\/s41598-020-64747-1"},{"key":"170","doi-asserted-by":"crossref","unstructured":"Mei H, Qi C, Liu J, Yang S, Zhou J, Lu Y, Zheng L, Li J, Zhao L, Xu X. hTAS2R38 polymorphisms modulate oral microbiota and influence the prevalence and treatment outcome of halitosis. Microbiome. 2025;13(1):85.","DOI":"10.1186\/s40168-025-02087-w"},{"key":"171","doi-asserted-by":"crossref","unstructured":"Mukherjee C, Moyer CO, Steinkamp HM, Hashmi SB, Beall CJ, Guo X, Ni A, Leys EJ, Griffen AL. Acquisition of oral microbiota is driven by environment, not host genetics. Microbiome. 2021;9(1):54.","DOI":"10.1186\/s40168-020-00986-8"},{"key":"172","doi-asserted-by":"crossref","unstructured":"Zagury-Orly I, Khaouam N, Noujaim J, Desrosiers MY, Maniakas A. The effect of radiation and chemoradiation therapy on the head and neck mucosal microbiome: A review. Front Oncol. 2021;11:784457.","DOI":"10.3389\/fonc.2021.784457"},{"key":"173","doi-asserted-by":"crossref","unstructured":"Hong BY, Sobue T, Choquette L, Dupuy AK, Thompson A, Burleson JA, Salner AL, Schauer PK, Joshi P, Fox E, Shin DG, Weinstock GM, Strausbaugh LD, Dongari-Bagtzoglou A, Peterson DE, Diaz PI. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome. 2019;7(1):66.","DOI":"10.1186\/s40168-019-0679-5"},{"key":"174","doi-asserted-by":"crossref","unstructured":"Lopes Dos Santos Santiago G, Brusselle G, Dauwe K, Deschaght P, Verhofstede C, Vaneechoutte D, Deschepper E, Jordens P, Joos G, Vaneechoutte M. Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma. BMC Microbiol. 2017;17(1):109.","DOI":"10.1186\/s12866-017-1022-6"},{"key":"175","doi-asserted-by":"crossref","unstructured":"Kube\u010dek O, Paterov\u00e1 P, Novosadov\u00c3\u00a1 M. Risk factors for infections, antibiotic therapy, and its impact on cancer therapy outcomes for patients with solid tumors. Life. 2021;11(12):1387.","DOI":"10.3390\/life11121387"},{"key":"176","doi-asserted-by":"crossref","unstructured":"Eng L, Sutradhar R, Niu Y, Liu N, Liu Y, Kaliwal Y, Powis ML, Liu G, Peppercorn JM, Bedard PL, Krzyzanowska MK. Impact of antibiotic exposure before immune checkpoint inhibitor treatment on overall survival in older adults with cancer: A population-based study. J Clin Oncol. 2023;41(17):3122-34.","DOI":"10.1200\/JCO.22.00074"},{"key":"177","doi-asserted-by":"crossref","unstructured":"Son MY, Cho HS. Anticancer effects of gut microbiota-derived short-chain fatty acids in cancers. J Microbiol Biotechnol. 2023;33(7):849-56.","DOI":"10.4014\/jmb.2301.01031"},{"key":"178","doi-asserted-by":"crossref","unstructured":"Mojdami ZD, Barbour A, Oveisi M, Sun C, Fine N, Saha S, Marks C, Elebyary O, Watson E, Tenenbaum H, Azarpazhooh A, Glogauer M. The effect of intensity-modulated radiotherapy to the head and neck region on the oral innate immune response and oral microbiome: A prospective cohort study of head and neck tumour patients. Int J Mol Sci. 2022;23(17):9594.","DOI":"10.3390\/ijms23179594"},{"key":"179","doi-asserted-by":"crossref","unstructured":"Wang XX, Liu YT, Ren JG, Liu HM, Fu Q, Yang Y, Fu QY, Chen G. Salivary Microbiome relates to neoadjuvant immunotherapy response in OSCC. J Dent Res. 2024;103(10):988-98.","DOI":"10.1177\/00220345241262759"},{"key":"180","doi-asserted-by":"crossref","unstructured":"Shoji F, Yamaguchi M, Okamoto M, Takamori S, Yamazaki K, Okamoto T, Maehara Y. Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer. Front Mol Biosci. 2022;9:1040424.","DOI":"10.3389\/fmolb.2022.1040424"}],"container-title":["Critical Reviews\u2122 in Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/751524302091426a\/83-106-rev.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T07:05:31Z","timestamp":1750662331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/439f422d0783386a,09eb0aa2691d05f5,751524302091426a.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":179,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critrevoncog.2025059551","relation":{},"ISSN":["0893-9675"],"issn-type":[{"value":"0893-9675","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}